Point72 Asset Management
SRPT icon

Point72 Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Point72 Asset Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$675K Buy
+31,000
New +$600K ﹤0.01% 2988
2025
Q4 		– Sell
-145,000
Closed -$2.79M – 4160
2025
Q3 		$2.79M Buy
145,000
+95,000
+190% +$1.69M ﹤0.01% 1310
2025
Q2 		$855K Buy
50,000
+20,000
+67% +$853K ﹤0.01% 1608
2025
Q1 		$1.91M Buy
+30,000
New +$3.16M ﹤0.01% 1258
2023
Q4 		– Sell
-33,000
Closed -$4M – 2772
2023
Q3 		$4M Buy
+33,000
New +$3.73M 0.01% 953
2022
Q1 		– Sell
-16,500
Closed -$1.49M – 1381
2021
Q4 		$1.49M Buy
+16,500
New +$1.41M 0.01% 859
2019
Q2 		– Sell
-200,000
Closed -$23.8M – 1515
2019
Q1 		$23.8M Buy
+200,000
New +$25.7M 0.11% 214
2018
Q2 		– Sell
-100,000
Closed -$7.41M – 1169
2018
Q1 		$7.41M Sell
100,000
-100,000
-50% -$6.67M 0.03% 492
2017
Q4 		$11.1M Buy
+200,000
New +$10.6M 0.05% 424
2017
Q1 		– Sell
-100,000
Closed -$2.74M – 946
2016
Q4 		$2.74M Sell
100,000
-150,000
-60% -$6.02M 0.02% 524
2016
Q3 		$15.4M Hold
250,000
– – 0.11% 225
2016
Q2 		$4.77M Buy
+250,000
New +$4.63M 0.03% 434
2016
Q1 		– Sell
-380,200
Closed -$14.7M – 836
2015
Q4 		$14.7M Buy
+380,200
New +$12.3M 0.12% 205
2015
Q3 		– Sell
-174,900
Closed -$5.32M – 891
2015
Q2 		$5.32M Hold
174,900
– – 0.04% 436
2015
Q1 		$2.32M Sell
174,900
-100,300
-36% -$1.34M 0.02% 545
2014
Q4 		$3.98M Sell
275,200
-416,000
-60% -$7.04M 0.03% 470
2014
Q3 		$14.6M Buy
+691,200
New +$15.6M 0.11% 225

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Asset Management's SRPT Position: Q1 2026 in Review

Point72 Asset Management sold out of Sarepta Therapeutics (SRPT) in Q1 2026, closing a stake of 207,513 shares — an estimated $4.02M sold.

Point72 Asset Management first reported a position in SRPT in Q2 2014 and held it in 35 quarters. The position peaked at $202M in Q3 2016. 339 funds tracked by Wall St. Rank hold SRPT as of Q1 2026.

  • Point72 Asset Management reported no remaining Sarepta Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 207,513 Sarepta Therapeutics shares in Q1 2026, an estimated $4.02M.
  • Point72 Asset Management first reported a position in Sarepta Therapeutics in Q2 2014 and held it in 35 quarters.
  • Point72 Asset Management's Sarepta Therapeutics position peaked at $202M in Q3 2016.
  • 339 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.